期刊文献+

声辐射力脉冲成像技术对肝纤维化分级的应用价值 被引量:5

Application of acoustic radiation force impulse elastography to liver fibrosis stage
在线阅读 下载PDF
导出
摘要 目的探讨声辐射力脉冲成像技术(ARFI)对慢性乙型肝炎病毒引起的肝纤维化的诊断价值。方法对239例经肝穿刺活检病理检查、26例临床确诊的乙肝肝硬化患者(列为F4级),应用ARFI技术测定肝脏剪切波速,检测肝纤维化程度,根据病理S0~S4分期,将患者分为F0~F4级。比较ARFI与血清肝纤维化标志物对肝纤维化程度的诊断价值,建立本地区的最佳界限值。设立50例正常对照组。结果 239例肝活检患者中病理诊断为S0~S4期的病例数分别为58例、48例、54例、59例和20例,ARFI平均值分别为(1.17±0.25)m/s、(1.39±0.36)m/s、(1.91±0.49)m/s、(2.66±0.51)m/s、(2.75±0.41)m/s。265例中,F0期与F1期,F3期与F4期的ARFI值之间差异无统计学意义。F0期与F2期、F3期、F4期之间,F1期与F2期、F3期、F4期之间,F2期与F3期、F4期之间差异有统计学意义(P<0.05)。ARFI分级结果与肝纤维化病理分期的相关性高于血清肝纤维化标志物,肝剪切波速中值数2.7是ARFI检查肝纤维化与肝硬化的交界点。结论 ARFI技术可较客观的评价肝纤维化分级,为临床提供一种无创评价肝纤维化程度的检查方法。 Objective To explore the application value of acoustic radiation force impulse (ARFI) elastography in confirmation of the degree of hepatic fibrosis caused by chronic hepatitis B virus. Methods ARFI was applied to the patients with hepatic cirrhosis caused by HBV, 239 of whom were confirmed by aspiration biopsy and the other 26 of whom were clinically defined, in order to find out the degree of hepatic fibrosis via shear-wave speed. According to S0 - $4 scale by pathology, the cases were ranked as different stages ( F0 - F4 ). The diagnostic values of liver fibrosis were compared between ARFI and fibrotic marker in serum. The regional optimal cutoff value was established, Another 50 cases were enrolled as normal controls. Results Among the 239 cases of biopsy, the numbers ranked at the stage of So - S4 were 58, 48, 54, 59,20, respectively, and the mean values of liver shear wave speed in 5o-$4 were (1.17±0.25)m/s, (1.39±0.36)m/s, (1.91 ±0.49)m/s, (2.66 ± 0. 51) m/s and (2.75±0.41)m/s, re- spectively. Among 265 cases, there were no significant differences in the mean value of ARFI between F0 and F1 subgroups, or be- tween F3 and F4 subgroups. But there were significant differences in the mean value of ARFI between F0 and any of F2 - F4 sub- groups, or F1 and any of F2 - F4 subgroups, or between F2 and any of F3 - F4 subgroups (P 〈 0.05). The correlation between ARFI grading and pathologic staging was higher than that between serum markers and pathologic staging. In ARFI elastography, the optimal cutoff value was 2.7 ( liver shear-wave speed) as the separating point of liver fibrosis and liver cirrhosis. Conclusion ARFI technology can evaluate liver fibrosis stage, and it is a new noninvasive method to the assessment of liver fibrosis.
出处 《临床军医杂志》 CAS 2013年第3期300-303,共4页 Clinical Journal of Medical Officers
关键词 肝纤维化 声辐射力脉冲成像技术 血清肝纤维化标志物 病理分期 liver fibrosis acoustic radiation force impulse fibrosis marker in serum pathologic stage
  • 相关文献

参考文献15

二级参考文献53

共引文献14289

同被引文献57

  • 1陈巍,翁彭剑,高国生,颜华东,毛达峰,祝成亮.剪切波速与四种无创血清评分系统对慢性肝炎患者肝纤维化诊断效果的比较[J].中华临床感染病杂志,2013,6(5):269-272. 被引量:11
  • 2中华医学会传染病与寄生虫病学分会.肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19:56-62.
  • 3Coumane S,Browne JE,Fagan AJ. The effects of fatty deposits on the accuracy of the Fibroscan? liver transient elastography ultrasound sys-tem[J].Phys Med Biol,2012,57(12):3901-3914.
  • 4Wang T,Jing Y. Transcranial ultrasound imaging with speed of sound-based phase correction: a numerical study [J]. Phys Med Biol,2013,58(19):6663-6681.
  • 5刘京,彭忠田.ARFI、FibrcScan无创诊断肝纤维化的研究进展[J].健康必读(下旬刊),2013(9):578-544.
  • 6Fontanarosa D,Pesente S,Pascoli F,et al. A speed of sound aberration correction algorithm for curvilinear ultrasound transducers in ultrasound-based image-guided radiotherapy[J]. Phys Med Biol,2013,58(5):1341-1360.
  • 7Attia D,Rifai K,Pischke S,et al.Impact of intrahepatic cholestasis on liver stiffness measurement using Acoustic radiation force impulse imaging(ARFI)[J].Zeitschrift Für Gastroenterologie,2013,183(6):2171.
  • 8Silva Junior R G,Schmillevitch J,Nascimento M F,et al.Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C[J].Scand J Gastroenterol,2014,49(8):986.
  • 9Razek A A K A,Khashaba M,Abdalla A,et al.Apparent diffusion coefficient value of hepatic fibrosis and inflammation in children with chronic hepatitis[J].Radiol Med,2014,119(12):903.
  • 10Chen Y C,Peng C Y,Jeng W J,et al.Clinical outcomes after interruption of entecavir therapy in HBe Ag-negative chronic hepatitis B patients with compensated cirrhosis[J].Aliment Pharmacol Ther,2015,42(10):1182.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部